Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check7 days agoChange DetectedAdded a Study Status section to the Record History page and updated to Revision: v3.4.3 (2026-03-09). The previous revision v3.4.2 (2025-12-26) was deleted.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page history shows Revision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor update to the history entries rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.4.1 has been added to the history, and the notices about funding lapse and Revision: v3.4.0 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange Detected- Show glossary option and color-coded change indicators (green for additions, red for deletions) on the Record History page. A new revision label (Revision: v3.4.0) is displayed to reflect the update.SummaryDifference0.6%

- Check57 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page, indicating a minor update to the site’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.